alisertib,paclitaxel
puma
['alisertib', 'biomarker', 'breast', 'paclitaxel', 'puma']
puma biotechnology announces presentation of biomarker findings from a phase ii study of alisertib with paclitaxel versus paclitaxel alone in metastatic or locally recurrent breast cancer at the 2023 asco annual meeting #alisertib #announces #annual 
Today's News for Tomorrow's Investor
📈 Do your own DD
🇨🇦  #TSX #TSXV #CSEstocks
🇺🇸  #OTCmarkets